blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1852127

EP1852127 - Use of a B-cell-depleting antibody for treatment of polyoma virus infections [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.11.2009
Database last updated on 06.07.2024
Most recent event   Tooltip06.11.2009Application deemed to be withdrawnpublished on 09.12.2009  [2009/50]
Applicant(s)For all designated states
Charité - Universitätsmedizin Berlin
Schumannstrasse 20/21
10117 Berlin / DE
[2007/45]
Inventor(s)01 / Reinke, Petra
Rathausstrasse 11
10178 Berlin / DE
02 / Volk, Hans-Dieter
Rathausstrasse 11
10178 Berlin / DE
03 / Hammer, Markus
Methfesselstrasse 38
10965 Berlin / DE
04 / Babel, Nina
Schonacherstrasse 21
13469 Berlin / DE
05 / Bold, Gana
Rigastrasse 79
10247 Berlin / DE
 [2007/45]
Representative(s)Engelhard, Markus
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[N/P]
Former [2007/45]Engelhard, Markus
Forrester & Boehmert Pettenkoferstrasse 20-22
80336 München / DE
Application number, filing date06009050.302.05.2006
[2007/45]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1852127
Date:07.11.2007
Language:EN
[2007/45]
Search report(s)(Supplementary) European search report - dispatched on:EP30.10.2006
ClassificationIPC:A61K39/395, A61P31/20, A61K31/675, // A61P13/12, A61P37/06, C07K16/28
[2007/45]
CPC:
C07K16/2887 (EP,US); A61P13/12 (EP); A61P31/20 (EP);
A61P37/06 (EP); A61K2039/505 (EP,US); C07K2317/24 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/45]
TitleGerman:Verwendung eines B-Zell entfernenden Antikörpers zur Behandlung von Polyoma Virusinfektionen[2007/45]
English:Use of a B-cell-depleting antibody for treatment of polyoma virus infections[2007/45]
French:Utilisation d'un anticorps à action déplétive des cellules B pour le traitement des infections par le virus de polyoma[2007/45]
Examination procedure30.04.2008Examination requested  [2008/24]
30.07.2008Despatch of a communication from the examining division (Time limit: M04)
04.12.2008Reply to a communication from the examining division
05.02.2009Communication of intention to grant the patent
16.06.2009Application deemed to be withdrawn, date of legal effect  [2009/50]
22.07.2009Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2009/50]
Fees paidRenewal fee
14.05.2008Renewal fee patent year 03
12.05.2009Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]JPH0967397  ;
 [DA]US6605602  (VATS ABHAY N [US]) [DA] 1-23 * example - ** claim - *;
 [A]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 97, no. 20, Database accession no. 1997-221794, XP002402033 & JPH0967397 A 19970311 (EISAI CO. LTD.) [A] 1-23 * column A *
 [A]  - M. AHUJA ET AL., "Polyoma virus infection after renal transplantation.", TRANSPLANTATION, USA, (20010415), vol. 71, no. 7, pages 896 - 899, XP002401911 [A] 1-23 * abstract *
 [A]  - S. SESHAN ET AL., "Immunophenotyping of BK virus nephropathy and acute allograft rejection: Potential diagnostic and prognostic markers.", LABORATORY INVESTIGATION, (200201), vol. 82, no. 1, page 280A, XP008069689 [A] 1-23 * abstract 1162, conclusions *
 [A]  - D. SANSONNO ET AL., "Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.", BLOOD, USA, (20030515), vol. 101, no. 10, pages 3818 - 3826, XP002401908 [A] 1-23 * abstract * * discussion *

DOI:   http://dx.doi.org/10.1182/blood-2002-10-3162
 [A]  - D. ROCCATELLO ET AL., "Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.", NEPHROLOGY, DIALYSIS, TRANSPLANTATION, GB, (200412), vol. 19, no. 12, pages 3054 - 3061, XP002401909 [A] 1-23 * abstract * * discussion *
 [A]  - J. HERMAN ET AL., "Successful treatment with Rituximab of lymphoproliferative disorder in a child after cardiac transplantation.", THE JOURNAL OF HEART AND LUNG TRANSPLANTATION, USA, (200212), vol. 21, no. 12, pages 1304 - 1309, XP002401910 [A] 1-23 * abstract * * discussion *
 [A]  - F. BRITO-BABAPULLE ET AL., "Progressive multifocal leucoencephalopathy (PML) following Rituximab-combination chemotherapy treatment.", BRITISH JOURNAL OF HAEMATOLOGY, GB, (20060405), vol. 133, no. suppl.1, page 36, XP008069690 [A] 1-23 * abstract 38 *
 [A]  - A. CHANG ET AL., "CD3 and CD20 immunohistochemistry of renal transplant biopsies with polyoma virus-associated nephritis or acute allograft rejection.", MODERN PATHOLOGY, (200301), vol. 16, no. 1, page 266A, XP008069688 [A] 1-23 * abstract 1213, conclusions *
by applicantJPH0967397B
 US6605602
    - RANDHAWA ET AL., TRANSPLANTATION, (2003), vol. 71, pages 1300 - 1303
    - KWAK ET AL., CLINICAL INFECTIOUS DISEASES, (2006), vol. 35, pages 1081 - 1087
    - AHUJA ET AL., TRANSPLANTATION, (2001), vol. 71, pages 896 - 899
    - SESHAN ET AL., LABORATORY INVESTIGATION, (2002), vol. 82, page 280
    - SANSONNO ET AL., BLOOD, (2003), vol. 101, pages 3818 - 3826
    - ROCCATELLO ET AL., NEPHROLOGY, DIALYSIS, TRANSPLANTATION, (2004), vol. 19, pages 3054 - 3061
    - HERMAN ET AL., THE JOURNAL OF HEART AND LUNG TRANSPLANTATION, (2002), vol. 21, pages 1304 - 1309
    - BRITO-BABAPULLE ET AL., BRITISH JOURNAL OF HEMATOLOGY, (2006), vol. 133, page 36
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.